Evaluation of the Effectiveness of Enhanced Recovery After Surgery (ERAS) Program in Pediatric Lung Surgery
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Enhanced Recovery After Surgery, ERAS.
- Who it may be relevant to
- Registry conditions: Lung Surgery, Enhanced Recovery After Surgery, ERAS, Pediatric. Basic parameters: 0 years — 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Taiwan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study aims to evaluate the clinical effectiveness of the Enhanced Recovery After Surgery (ERAS) program for pediatric lung surgery at our institution.
Detailed description
Using a prospective cohort design, we will observe pediatric patients undergoing lung surgery following the implementation of the ERAS program as standard practice. Outcomes will be compared with a historical control group (2014-2023) to assess whether ERAS reduces hospital length of stay, lowers postoperative complication rates, accelerates recovery, and decreases healthcare costs.
Interventions
- Other Enhanced Recovery After Surgery, ERAS
During the study period, all enrolled patients will be managed according to our institution's consensus checklist for pediatric lung surgery ERAS care. This includes ERAS education, preoperative assessment, fasting guidance, prophylaxis for nausea and vomiting, standardized anesthesia and surgical protocols, preference for minimally invasive surgery, multimodal postoperative analgesia, and encouragement of early oral intake and mobilization.
Primary outcome measures
- Length of hospital stay [Time frame: Up to 30 days after surgery.]
Secondary outcome measures (9)
- Postoperative complications [Time frame: Within 30 days after surgery.]
- Duration of urinary catheter placement [Time frame: From date of surgery to catheter removal (up to 30 days)]
- Duration of chest tube drainage [Time frame: From date of surgery to chest tube removal (up to 30 days).]
- Intensive care unit stay [Time frame: From date of ICU admission to transfer out (up to 30 days).]
- Postoperative pain [Time frame: Daily assessment up to 7 days postoperatively.]
- Postoperative analgesic use [Time frame: Daily assessment up to 7 days postoperatively.]
- 30-day readmission or emergency department visit [Time frame: Within 30 days post-discharge.]
- Time to resumption of oral intake [Time frame: From date of surgery to initiation of oral intake (up to 7 days).]
- Hospital cost [Time frame: From date of admission to discharge, up to 30 days]
Eligibility criteria
Inclusion criteria
- Children who underwent lung surgery at our hospital's Division of Pediatric Surgery
Exclusion criteria
- Patients who underwent multiple surgeries (including surgeries other than lung surgery) during the same hospitalization
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Taiwan · 1 center
- National Taiwan University Hospital — Taipei
Publications
- Children 2021, 8(12), 1154
- Ha D, Harris KT, Brockel MA, Rove KO. The role of enhanced recovery after surgery (ERAS) in promoting quality improvement and patient safety in pediatric urology. Front Urol. 2023 Sep 28;3:1275276. doi: 10.3389/fruro.2023.1275276. eCollection 2023. PMID 40778051
Identifiers
NCT: NCT07241286 · 202504141RINE